Development, Standardisation and Standardisation Project for a New Memory Assessment

Launched by UNIVERSITY HOSPITAL, TOURS · Aug 19, 2024

Keywords

ClinConnect Summary

This clinical trial is studying a new memory assessment tool called the New Evaluation of Episodic Memory (NEM), which is designed to better understand memory in people with memory disorders, particularly Alzheimer’s disease. Current memory tests often overlook important aspects of how memories are formed and connected to our identities and emotions. The researchers believe that by using the NEM, they can provide more accurate diagnoses and insights into how Alzheimer’s affects memory.

To participate in this trial, individuals must be at least 50 years old and have a specific type of memory issue called amnesic Mild Cognitive Impairment (MCI). Participants will go through assessments to see how well they perform on the NEM tool compared to other memory tests. It's important to note that people with severe hearing or vision problems that could interfere with testing, or those who are under legal guardianship, are not eligible to join. This study is currently recruiting participants, and those who take part will help researchers learn more about memory disorders and improve future assessments.

Gender

ALL

Eligibility criteria

• Inclusion Criteria:
• • Age ≥ 50 years
• • Ability to understand judged sufficient by the assessor;
• • Amnesic MCI profile (Petersen, 2003) during the 1st medical consultation prior to the assessment being prescribed.
• Exclusion Criteria:
• • Severe auditory and/or visual sensory impairment not compatible with neuropsychological assessment;
• • Judged fit to take the test by the assessor;
• • Patient under guardianship, curatorship or family guardianship;
• • Opposition to data processing.